MX2023007241A - Sintesis de nucleosidos antivirales. - Google Patents

Sintesis de nucleosidos antivirales.

Info

Publication number
MX2023007241A
MX2023007241A MX2023007241A MX2023007241A MX2023007241A MX 2023007241 A MX2023007241 A MX 2023007241A MX 2023007241 A MX2023007241 A MX 2023007241A MX 2023007241 A MX2023007241 A MX 2023007241A MX 2023007241 A MX2023007241 A MX 2023007241A
Authority
MX
Mexico
Prior art keywords
methylpropanoate
preparation
synthesis
methods
present
Prior art date
Application number
MX2023007241A
Other languages
English (en)
Inventor
Hao Yang
Anna Fryszkowska
Jongrock Kong
Tamas Benkovics
Kevin M Maloney
Mark A Huffman
Patrick S Fier
Steven M Silverman
Tetsuji Itoh
Peter E Maligres
John Mcintosh
Grant S Murphy
Original Assignee
Merck Sharp & Dohme Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Llc filed Critical Merck Sharp & Dohme Llc
Publication of MX2023007241A publication Critical patent/MX2023007241A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/385—Pyrimidine nucleosides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y102/00—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/03—Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with oxygen as acceptor (1.2.3)
    • C12Y102/03003—Pyruvate oxidase (1.2.3.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01006—Catalase (1.11.1.6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/02—Pentosyltransferases (2.4.2)
    • C12Y204/02003—Uridine phosphorylase (2.4.2.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
    • C12Y207/011—S-Methyl-5-thioribose kinase (2.7.1.100)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/02—Phosphotransferases with a carboxy group as acceptor (2.7.2)
    • C12Y207/02001—Acetate kinase (2.7.2.1)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

La presente invención se relaciona con procesos sintéticos eficientes útiles en la preparación de nucleósidos antivirales, particularmente uridina 4-oxima 5'-(2-metilpropanoato) {(2R,3S,4R,5R)-3,4-dihidroxi-5-[4-(hidroxiimino)-2-oxo-3,4-dihidr opirimidin-1(2H)-il]oxolan-2-il}metil 2-metilpropanoato y sales, derivados, tautómeros, isómeros y profármacos farmacéuticamente aceptables, que pueden ser activos como agentes antivirales, así como sus composiciones y métodos. La presente invención también abarca intermediarios útiles en los procesos sintéticos divulgados y los métodos para su preparación.
MX2023007241A 2020-12-18 2021-12-17 Sintesis de nucleosidos antivirales. MX2023007241A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063127484P 2020-12-18 2020-12-18
US202163182171P 2021-04-30 2021-04-30
US202163192912P 2021-05-25 2021-05-25
PCT/US2021/064021 WO2022133205A1 (en) 2020-12-18 2021-12-17 Synthesis of antiviral nucleosides

Publications (1)

Publication Number Publication Date
MX2023007241A true MX2023007241A (es) 2023-06-29

Family

ID=82058167

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023007241A MX2023007241A (es) 2020-12-18 2021-12-17 Sintesis de nucleosidos antivirales.

Country Status (8)

Country Link
US (1) US20240092818A1 (es)
EP (1) EP4262816A4 (es)
JP (1) JP2023552230A (es)
KR (1) KR20230121622A (es)
AU (1) AU2021401398A1 (es)
CA (1) CA3201732A1 (es)
MX (1) MX2023007241A (es)
WO (1) WO2022133205A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115785181B (zh) * 2022-11-30 2023-08-29 山东诚汇双达药业有限公司 一锅法制备莫匹拉韦中间体的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3082191C (en) * 2017-12-07 2021-09-21 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
AU2019231725A1 (en) * 2018-03-07 2020-10-08 Emory University 4'-halogen containing nucleotide and nucleoside therapeutic compositions and uses related thereto

Also Published As

Publication number Publication date
KR20230121622A (ko) 2023-08-18
AU2021401398A1 (en) 2023-06-29
US20240092818A1 (en) 2024-03-21
EP4262816A1 (en) 2023-10-25
CA3201732A1 (en) 2022-06-23
WO2022133205A1 (en) 2022-06-23
JP2023552230A (ja) 2023-12-14
EP4262816A4 (en) 2024-05-15

Similar Documents

Publication Publication Date Title
AU782948B2 (en) Prodrugs of HIV replication inhibiting pyrimidines
JP2868671B2 (ja) 抗ウイルス組合せ
MD20150036A2 (ro) Analogi de 2'-cloro nucleozide pentru tratarea hepatitei virale C
TW200738741A (en) Antiviral compounds
TW200738742A (en) Antiviral compounds
TW200745151A (en) Antiviral nucleosides
MX2007001059A (es) Conjugados de fosfonato de nucleosido como agentes contra vih.
MX2007000584A (es) Compuestos antivirales.
WO2007078523A3 (en) 5-phenyl-3-benzyl-0xaz0lidin-2-0ne derivatives and related compounds as metabotropic glutamate receptor potentiators for the treatment of neurological and psychiatric disorders
MA32135B1 (fr) Inhibiteurs de pim kinase et leurs procedes d'utilisation
MX2007004979A (es) Derivados de indol tetraciclicos como agentes antiviricos.
DK1725536T3 (da) Imidazolin-derivater med CB1-antagonistisk aktivitet
EA200800162A1 (ru) Новые фармацевтические композиции с замедленным высвобождением и способы их получения
WO2007084914A3 (en) Phenoxy-substituted pyrimidines as adenosine receptor antagonists
TW200716583A (en) Crystal forms of {[(2R)-7-(2,6-dichlorophenyl)-5-fluoro-2,3-dihydro-1-benzofuran-2-yl]methyl}amine hydrochloride
WO2003084935A3 (en) Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases
MX2023007241A (es) Sintesis de nucleosidos antivirales.
WO2007017728A3 (en) Novel heterocyclic compounds
TW200612965A (en) Methods for preparing p2x7 inhibitors
WO2008116185A3 (en) Substituted pyrimidines as adenosine receptor antagonists
MY140858A (en) Ampa receptor potentiators
DK1523486T3 (da) Tetracykliske arylsulfonylindoler med serotoninreceptor-affinitet
PL1893597T3 (pl) Związki wspomagające działanie receptora AMPA
WO2006109146A3 (en) Novel heterocyclic derivatives
WO2002062798A3 (en) Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose